Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Synthesis of conformationally constrained D-Glu-meso-DAP analogs as innate immune agonists
ID
Guzelj, Samo
(
Author
),
ID
Jakopin, Žiga
(
Author
)
PDF - Presentation file,
Download
(1,65 MB)
MD5: CD61878330E2605F69E7C51A7AA198A2
URL - Source URL, Visit
https://www.mdpi.com/1420-3049/25/22/5228
Image galllery
Abstract
The dipeptide D-Glu-meso-DAP (iE-DAP) is the minimal structural fragment capable of activating the innate immune receptor nucleotide-binding oligomerization domain protein (NOD1). The meso-diaminopimelic acid (meso-DAP) moiety is known to be very stringent in terms of the allowed structural modifications which still retain the NOD1 activity. The aim of our study was to further explore the chemical space around the meso-DAP portion and provide a deeper understanding of the structural features required for NOD1 agonism. In order to achieve the rigidization of the terminal amine functionality of meso-DAP, isoxazoline and pyridine heterocycles were introduced into its side-chain. Further, we incorporated the obtained meso-DAP mimetics into the structure of iE-DAP. Collectively, nine innovative iE-DAP derivatives additionally equipped with lauroyl or didodecyl moieties at the α-amino group of D-Glu have been prepared and examined for their NOD1 activating capacity. Overall, the results obtained indicate that constraining the terminal amino group of meso-DAP abrogates the compounds ability to activate NOD1, since only compound 6b retained noteworthy NOD1 agonistic activity, and underpin the stringent nature of this amino acid with regard to the allowed structural modifications.
Language:
English
Keywords:
NOD1 agonist
,
constrained meso-DAP mimetics
,
NOD1 activation
,
innate immune agonist
,
bioisosteric replacement
,
rigidization
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2020
Number of pages:
13 str.
Numbering:
Vol. 25, iss. 22, art. 5228
PID:
20.500.12556/RUL-134690
UDC:
663.2:663.4:547.56:66.094.3.097.8
ISSN on article:
1420-3049
DOI:
10.3390/molecules25225228
COBISS.SI-ID:
36482307
Publication date in RUL:
26.01.2022
Views:
640
Downloads:
184
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Molecules
Shortened title:
Molecules
Publisher:
MDPI
ISSN:
1420-3049
COBISS.SI-ID:
18462981
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:
10.11.2020
Secondary language
Language:
Slovenian
Keywords:
agonist prirojene imunosti
,
bioizosterna zamenjava
,
NOD1 agonisti
,
aktivacija NOD1
,
rigidizirani mimetiki mezo-DAP
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0208
Name:
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin
Funder:
ARRS - Slovenian Research Agency
Project number:
J3-9256
Name:
Razvoj agonistov receptorja NOD2 ter dualnih NOD2/TLR7 agonističnih konjugatov kot novih adjuvansov za cepiva
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back